NCT01790685View on ClinicalTrials.gov

Ozurdex for Retinal Vein Occlusion Study (ORVO Study)

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Retinal Vein Occlusion

Interventions

DRUG

dexamethasone implant

Trial Locations (1)

21287

Wilmer Eye Institute, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Allergan

INDUSTRY

lead

Johns Hopkins University

OTHER